Iran-Israel Conflict Threatens Global Medicine Supply, Warns German Industry

A leading German pharmaceutical industry group is warning that a prolonged war between Iran and Israel could severely disrupt global drug supplies. The Association of Research-Based Pharmaceutical Companies (vfa) stated that the conflict risks causing significant delivery delays for medicines. Key ingredients and finished drugs often pass through the Middle East, a major transit region. "The longer the conflict drags on, the more likely it is that there will be delivery delays," said vfa economist Siegfried Throm. The warning highlights the fragility of international supply chains. Many pharmaceuticals rely on ingredients sourced from around the world. Disruptions to air and sea routes, increased insurance costs, and regional instability could all contribute to shortages. Germany's pharmaceutical sector is a global leader, making the warning particularly significant for hospitals and patients worldwide. The industry group is urging companies to review their supply lines and prepare contingency plans.